QUAY STEVEN C 4
4 · ATOSSA THERAPEUTICS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2025-05-15+1,366,062→ 1,366,062 totalExercise: $0.99Exp: 2035-05-15→ Common Stock (1,366,062 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 24 months following May 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on May 15, 2025, with an exercise price of $0.99, representing the closing stock price on May 15, 2025.